Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416541569> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W2416541569 endingPage "24" @default.
- W2416541569 startingPage "S17" @default.
- W2416541569 abstract "The goal of epilepsy treatment is complete seizure control with minimal adverse drug reactions. Because no drug is entirely free of adverse effects, the clinician must aim for a balance between efficacy and tolerability. In approximately 40% of patients, however, monotherapy with conventional antiepileptic drugs either is not tolerated or does not provide optimal seizure control. Polypharmacy may be necessary in as many as 30% of patients. As clinicians look to new agents that may produce an overall improved quality of life, they must continue to balance efficacy and adverse effects in evaluating the usefulness of the new vs the established drugs." @default.
- W2416541569 created "2016-06-24" @default.
- W2416541569 creator A5004328544 @default.
- W2416541569 date "1995-03-01" @default.
- W2416541569 modified "2023-10-03" @default.
- W2416541569 title "Antiepileptic drug therapy in the United States: a review of clinical studies and unmet needs." @default.
- W2416541569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7898741" @default.
- W2416541569 hasPublicationYear "1995" @default.
- W2416541569 type Work @default.
- W2416541569 sameAs 2416541569 @default.
- W2416541569 citedByCount "8" @default.
- W2416541569 countsByYear W24165415692012 @default.
- W2416541569 crossrefType "journal-article" @default.
- W2416541569 hasAuthorship W2416541569A5004328544 @default.
- W2416541569 hasConcept C118552586 @default.
- W2416541569 hasConcept C159110408 @default.
- W2416541569 hasConcept C177713679 @default.
- W2416541569 hasConcept C197934379 @default.
- W2416541569 hasConcept C2778186239 @default.
- W2416541569 hasConcept C2778375690 @default.
- W2416541569 hasConcept C2779951463 @default.
- W2416541569 hasConcept C2780035454 @default.
- W2416541569 hasConcept C2994127763 @default.
- W2416541569 hasConcept C36434225 @default.
- W2416541569 hasConcept C71924100 @default.
- W2416541569 hasConcept C98274493 @default.
- W2416541569 hasConceptScore W2416541569C118552586 @default.
- W2416541569 hasConceptScore W2416541569C159110408 @default.
- W2416541569 hasConceptScore W2416541569C177713679 @default.
- W2416541569 hasConceptScore W2416541569C197934379 @default.
- W2416541569 hasConceptScore W2416541569C2778186239 @default.
- W2416541569 hasConceptScore W2416541569C2778375690 @default.
- W2416541569 hasConceptScore W2416541569C2779951463 @default.
- W2416541569 hasConceptScore W2416541569C2780035454 @default.
- W2416541569 hasConceptScore W2416541569C2994127763 @default.
- W2416541569 hasConceptScore W2416541569C36434225 @default.
- W2416541569 hasConceptScore W2416541569C71924100 @default.
- W2416541569 hasConceptScore W2416541569C98274493 @default.
- W2416541569 hasIssue "3 Suppl 2" @default.
- W2416541569 hasLocation W24165415691 @default.
- W2416541569 hasOpenAccess W2416541569 @default.
- W2416541569 hasPrimaryLocation W24165415691 @default.
- W2416541569 hasRelatedWork W1970252617 @default.
- W2416541569 hasRelatedWork W1984013967 @default.
- W2416541569 hasRelatedWork W2020177921 @default.
- W2416541569 hasRelatedWork W2025114653 @default.
- W2416541569 hasRelatedWork W2288622325 @default.
- W2416541569 hasRelatedWork W2300743134 @default.
- W2416541569 hasRelatedWork W2416541569 @default.
- W2416541569 hasRelatedWork W2560633658 @default.
- W2416541569 hasRelatedWork W2617677677 @default.
- W2416541569 hasRelatedWork W4288097168 @default.
- W2416541569 hasVolume "45" @default.
- W2416541569 isParatext "false" @default.
- W2416541569 isRetracted "false" @default.
- W2416541569 magId "2416541569" @default.
- W2416541569 workType "article" @default.